filmov
tv
New Hope for Women’s Reproductive Cancers
Показать описание
How can we overcome the numerous challenges in treating women’s reproductive cancers?
Hear from our panel of experts Ursula Matulonis, MD, Sohrab Shah, PhD, and Laura Andres-Martin, PhD, on how the latest advances in cancer and stem cell research are now being applied to develop precision therapies for women with reproductive cancers. This discussion was moderated by NYSCF’s Raeka Aiyar, PhD.
What you’ll learn:
- What new therapies are on the horizon for treating women’s reproductive cancers including cervical cancer, ovarian cancer, and uterine cancer
- How years of neglect in funding and public attention to women’s cancers has hindered research and patient care
- How we can overcome gender and racial health disparities in cancer outcomes
- How NYSCF is using the power of stem cells to create opportunities for more effective, tailored cancer treatments
About Dr. Ursula Matulonis (Chief and Director of the Division of Gynecologic Oncology, Dana-Farber Cancer Institute)
Dr. Matulonis is a world-recognized leader in gynecologic cancers, leading multiple clinical trials and translational research projects in ovarian cancer
Dr. Matulonis’ research focuses on developing new targeted therapies for gynecologic cancers
About Dr. Sohrab Shah (Chief of Computational Oncology, Memorial Sloan Kettering Cancer Center)
Dr. Shah uses computational methods, including machine learning, to understand tumor progression and varying patient responses to treatments
Dr. Shah has made pivotal contributions to understanding tumor evolution and variability in ovarian cancer
About Dr. Laura Andres-Martin (Research Investigator in Oncology, The NYSCF Research Institute)
Dr. Andres-Martin leads the NYSCF Women’s Reproductive Cancers Initiative, which aims to shift paradigms in the way women’s cancers are studied and treated
Dr. Andres-Martin’s team has built a biobank of ovarian cancer patient samples to fuel the discovery of personalized therapies
Chapters
0:00 - Welcome from NYSCF CEO & Founder Susan L. Solomon
5:41 - What treatment options are currently available for ovarian cancer patients?
11:06 - How do you treat cancers with complex genetics?
16:34 - How can stem cell technology tackle cancer?
23:13 - What factors drive disparities in research funding for ovarian cancer vs. other cancer types?
27:42 - What research is most likely to improve the outlook for ovarian cancer?
37:40 - Most promising clinical trials
51:11 - Immunotherapies in ovarian cancer
56:06 - Inspiring cases of recent innovation in ovarian cancer research
#cancer
#cancerresearch
#cervicalcancer
#ovariancancer
Hear from our panel of experts Ursula Matulonis, MD, Sohrab Shah, PhD, and Laura Andres-Martin, PhD, on how the latest advances in cancer and stem cell research are now being applied to develop precision therapies for women with reproductive cancers. This discussion was moderated by NYSCF’s Raeka Aiyar, PhD.
What you’ll learn:
- What new therapies are on the horizon for treating women’s reproductive cancers including cervical cancer, ovarian cancer, and uterine cancer
- How years of neglect in funding and public attention to women’s cancers has hindered research and patient care
- How we can overcome gender and racial health disparities in cancer outcomes
- How NYSCF is using the power of stem cells to create opportunities for more effective, tailored cancer treatments
About Dr. Ursula Matulonis (Chief and Director of the Division of Gynecologic Oncology, Dana-Farber Cancer Institute)
Dr. Matulonis is a world-recognized leader in gynecologic cancers, leading multiple clinical trials and translational research projects in ovarian cancer
Dr. Matulonis’ research focuses on developing new targeted therapies for gynecologic cancers
About Dr. Sohrab Shah (Chief of Computational Oncology, Memorial Sloan Kettering Cancer Center)
Dr. Shah uses computational methods, including machine learning, to understand tumor progression and varying patient responses to treatments
Dr. Shah has made pivotal contributions to understanding tumor evolution and variability in ovarian cancer
About Dr. Laura Andres-Martin (Research Investigator in Oncology, The NYSCF Research Institute)
Dr. Andres-Martin leads the NYSCF Women’s Reproductive Cancers Initiative, which aims to shift paradigms in the way women’s cancers are studied and treated
Dr. Andres-Martin’s team has built a biobank of ovarian cancer patient samples to fuel the discovery of personalized therapies
Chapters
0:00 - Welcome from NYSCF CEO & Founder Susan L. Solomon
5:41 - What treatment options are currently available for ovarian cancer patients?
11:06 - How do you treat cancers with complex genetics?
16:34 - How can stem cell technology tackle cancer?
23:13 - What factors drive disparities in research funding for ovarian cancer vs. other cancer types?
27:42 - What research is most likely to improve the outlook for ovarian cancer?
37:40 - Most promising clinical trials
51:11 - Immunotherapies in ovarian cancer
56:06 - Inspiring cases of recent innovation in ovarian cancer research
#cancer
#cancerresearch
#cervicalcancer
#ovariancancer
0:59:57
0:00:49
0:04:07
0:05:43
0:05:04
0:14:51
0:42:53
0:05:51
0:09:57
0:02:00
0:04:09
0:00:37
0:01:01
0:00:59
0:03:11
0:06:10
0:02:42
0:09:14
0:10:14
0:03:17
0:01:21
0:09:18
0:02:13
0:01:11